Filters

Zinan Feng

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Theoretical Biology|June 2, 2007
The community structure of human cellular signaling networkYuanbo Diao, Menglong Li, Zinan Feng, et al.
The Journal of Gene Medicine|July 16, 2021
Get ready for the CRISPR/Cas system: A beginner's guide to the engineering and design of guide RNAsShufeng Ma, Jie Lv, Zinan Feng, et al.
BMC Medicine|December 30, 2024
Intensified conditioning containing decitabine versus standard myeloablative conditioning for adult patients with KMT2A-rearranged leukemia: a multicenter retrospective studyZhongli Hu, Zinan Feng, Shiqi Liu, et al.
American Journal of Hematology|November 16, 2024
A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph<sup>+</sup> acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort studyHui Liu, Hui Xu, Peiru Chi, et al.
Experimental Hematology & Oncology|July 7, 2026
Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative studySijian Yu, Hui Liu, Weihua Zhao, et al.
Leukemia|May 28, 2025
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trialYu Zhang, Zinan Feng, Jing Du, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Theoretical Biology|June 2, 2007
The community structure of human cellular signaling networkYuanbo Diao, Menglong Li, Zinan Feng, et al.
The Journal of Gene Medicine|July 16, 2021
Get ready for the CRISPR/Cas system: A beginner's guide to the engineering and design of guide RNAsShufeng Ma, Jie Lv, Zinan Feng, et al.
BMC Medicine|December 30, 2024
Intensified conditioning containing decitabine versus standard myeloablative conditioning for adult patients with KMT2A-rearranged leukemia: a multicenter retrospective studyZhongli Hu, Zinan Feng, Shiqi Liu, et al.
American Journal of Hematology|November 16, 2024
A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph<sup>+</sup> acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort studyHui Liu, Hui Xu, Peiru Chi, et al.
Experimental Hematology & Oncology|July 7, 2026
Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative studySijian Yu, Hui Liu, Weihua Zhao, et al.
Leukemia|May 28, 2025
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trialYu Zhang, Zinan Feng, Jing Du, et al.
Pageof 1
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us